Paraquat-induced pulmonary fibrosis starts at an early stage of inflammation in rats

Immunotherapy

Volumn 4, Issue 12, 2012, Pages 1809-1815

  Xie, Hui ^a   Wang, Ruilan ^a   Tang, Xue ^a   Xiong, Ying ^a   Xu, Rong ^a   Wu, Xin ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

smooth muscle actin; collagen III; inflammation; paraquat; pulmonary fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 3; EOSIN; HEMATOXYLIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; LUNG FIBROSIS; LUNG LAVAGE; MALE; NONHUMAN; PARAQUAT POISONING; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING;

ACTINS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HERBICIDES; HUMANS; INFLAMMATION; LUNG; MALE; PARAQUAT; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84871242957     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.12.122     Document Type: Article

References (28)

1. Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology 180(1), 65-77 (2002).
2. Agarwal R, Srinivas R, Aggarwal AN et al. Experience with paraquat poisoning in a respiratory intensive care unit in North India. Singapore Med. J. 47(12), 1033-1037 (2006).
3. Dinis-Oliveira RJ, Duarte JA, Sénchez-Navarro A et al. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit. Rev. Toxicol. 38(1), 13-71 (2008).
4. Sun ML, Ma DH, Liu M et al. Successful treatment of paraquat poisoning by Xuebijing, an injection concocted from multiple Chinese medicinal herbs: a case report. J. Altern. Complement. Med. 15(12), 1375-1378 (2009).
5. Gray JP, Heck DE, Mishin V et al. Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H: paraquat oxidoreductase: identification of the enzyme as thioredoxin reductase. J. Biol Chem. 282(11), 7939-7949 (2007).
6. Hemmati AA, Nazari Z, Motlagh ME et al. The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat. Pharmacol. Res. 46(3), 229-234 (2002).
7. Gil HW, Oh MH, Woo KM et al. Relationship between pulmonary surfactant protein and lipid peroxidation in lung injury due to paraquat intoxication in rats. Korean J. Intern. Med. 22(2), 67-72 (2007).
8. Szapiel SV, Elson NA, Fulmer JD et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 120(4), 893-899 (1979).
9. Macneal K, Schwartz DA. The genetic and environmental causes of pulmonary fibrosis. Proc. Am. Thorac. Soc. 9(3), 120-125 (2012).
10. Fukumoto J, Harada C, Kawaguchi T et al. Amphiregulin attenuates bleomycin-induced pneumopathy in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 298(2), L131-L138 (2010).
11. Gao J, Feng LJ, Huang Y et al. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodeling. J. Pharm. Pharmacol. 64(6), 811-820 (2012).
12. Gao F, Kinnula VL, Myllärniemi M et al. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid. Redox Signal. 10(2), 343-354 (2008).
13. Abraham P, Wilfred G, Ramakrishna B. Plasma prolidase may be an index of liver fibrosis in the rat. Clin. Chim. Acta 295(1-2), 199-202 (2000).
14. Katre A, Ballinger C, Akhter H et al. Increased transforming growth factor beta1 expression mediates ozone-induced airway fibrosis in mice. Inhal. Toxicol. 23(8), 486-494 (2011).
15. Wu FH, Guo HX, Lin MF et al. Biomarker expression in lung of rabbit with pulmonary fibrosis induced by ammonium perchlorate. Toxicol. Ind. Health 27(3), 235-241 (2011).
16. Robb WB, Condron C, Moriarty M et al. Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice. Ir. J. Med. Sci. 179(1), 99-105 (2010).
17. Fine A, Goldstein RH. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J. Biol Chem. 262(8), 3897-3902 (1987).
18. Marshall RP, Bellingan G, Webb S et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am. J. Respir. Crit. Care Med. 162(5), 1783-1788 (2000).
19. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb. Haemost. 90(6), 993-1002 (2003).
20. Laumonier T, Michel M, Gabbiani G et al. Autologous transplantation of culture-born myofibroblasts into intact and injured rabbit ligaments. Int. Orthop. 36(8), 1733-1738 (2012).
21. Beon M, Harley RA, Wessels A et al. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin. Exp. Rheumatol. 22(6), 733-742 (2004).
22. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132(4), 1311-1321 (2007).
23. Hinz B, Phan SH, Thannickal VJ et al. The myofibroblast: one function, multiple origins. Am. J. Pathol. 170(6), 1807-1816 (2007).
24. Bogatkevich GS, Gustilo E, Oates JC et al. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 288(1), L190-L201 (2005).
25. Grotendorst GR, Rahmanie H, Duncan MR. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 18(3), 469-479 (2004).
26. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200(4), 500-503 (2003).
27. Ludwicka A, Trojanowska M, Smith EA et al. Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma. J. Rheumatol. 19(11), 1716-1723 (1992).
28. Silver RM, Wells AU. Histopathology and bronchoalveolar lavage. Rheumatology (Oxford) 47(Suppl. 5), V62-V64 (2008).